GOCO GoHealth, Inc.

GOCO financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1808220 Exchange: Nasdaq SIC: 6411 (Insurance Agents, Brokers & Service) Latest filing: 10-Q filed May 18, 2026 Data checked: Oct 21, 2026
Showing 3 of 7 annual and 0 of 26 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$32.90M (Jun 2025)
Industry (SIC)
6411 Insurance Agents, Brokers & Service
Incorporated
DE
Fiscal Year End
December (1231)
Phone
(312) 386-8200
EIN
000000000
Headquarters
CHICAGO, IL, 60654
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.

▼ Key Metrics (TTM)

As of Mar 31, 2026
Financials
Revenue
$152.79M
Net Income
$-289.89M
Total Assets
$917.92M
Total Equity
$-126.70M
Total Debt
$653.13M
Free Cash Flow
$-107.76M
Ratios
Gross Margin
57.3%
Operating Margin
-297.4%
Net Margin
-189.7%
Return on Equity
228.8%
Return on Assets
-31.6%
Current Ratio
2.03x
Debt / Equity
-5.15x
FCF / Assets
-11.7%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

GoHealth, Inc. generated $361.85M of revenue in fiscal 2025, with net loss of $257.13M and an operating cash outflow of $121.95M. At $361.85M, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Compared with $798.89M in fiscal 2024, revenue decreased 54.7%, a top-line contraction that reduced operating scale. The company reported diluted EPS of -$20.17, adding a shareholder-level measure to the absolute income figures considered below. Total assets stood at $987.38M, showing the scale of resources supporting revenue, earnings, liquidity, and financing. Revenue equaled 0.37x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

After reported cost of revenue, the company retained $265.72M as gross profit before recognizing operating expenses and other items. Gross margin was 73.4%, so that share of each revenue unit remained after the cost of revenue reported for the period. The company recorded an operating loss of $412.90M after the reported operating expense base. The operating loss equaled 114.1% of revenue, showing the scale of the operating deficit relative to sales. The company ended the period with a net loss of $257.13M, extending the operating result through all remaining items. The net loss equaled 71.1% of revenue, showing the bottom-line deficit relative to the company’s sales base. The company reported a pretax loss of $501.09M, before the effect of income taxes. Pretax margin was -138.5%, reflecting a pre-tax loss equal to 138.5% of revenue. The reported tax benefit was $3.33M, favorably bridging the pretax and after-tax results. The net loss equaled 26.0% of period-end assets, showing the deficit relative to the asset base.

Liquidity and Capital Structure

At period end, the $987.38M asset base was financed through $1.05B of liabilities and -$62.20M of equity. With total equity at -$62.20M, the company carried a negative book-capital position, increasing its reliance on liabilities and future earnings. At period end, current assets of $285.79M compared with current liabilities of $141.50M, defining the company’s short-term resource position. The current ratio was 2.02x, with current assets exceeding current liabilities and providing a short-term liquidity cushion. The company held $32.90M in cash and equivalents, a narrower liquidity measure than total current assets. Measured only with cash and equivalents, coverage of current liabilities was 23.3%, excluding receivables and other current assets. Borrowings totaled $636.74M, adding a fixed financing obligation alongside the company’s equity capital. Relative to total assets, debt measured 64.5%, showing how much of the asset base was matched by borrowing. The liabilities-to-assets relationship was 106.3%, placing reported obligations against the full positive asset balance. Cash and equivalents equaled 3.3% of total assets, showing the liquid cash component within the company’s broader resource base. The asset base changed 33.7% from $1.49B in fiscal 2024, leaving current total assets lower year over year. Reported equity changed 115.3% from $405.44M in fiscal 2024, placing the current capital base lower year over year.

Cash Flow and Earnings Quality

Operating activities used $121.95M of cash, resulting in an operating cash outflow for the year. The company spent $8.25M on capital expenditures while operations also absorbed cash, so both ongoing activity and investment drew on liquidity during the period. Negative free cash flow was $130.19M, leaving a cash deficit after capital spending and reducing financial flexibility. Free-cash-flow margin was -36.0%, reflecting a cash deficit equal to 36.0% of revenue after capital spending. The free-cash-flow deficit equaled 13.2% of total assets, placing the cash shortfall against the company’s resource base.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for GoHealth, Inc.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $361.85M $798.89M $734.67M
Cost of Revenue $96.13M $130.61M $158.96M
Gross Profit $265.72M $668.28M $575.71M
OPERATING EXPENSES
SG&A Expense $90.79M $82.12M $93.07M
Operating Income $-412.90M $-7.05M $-81.68M
NON-OPERATING INCOME / EXPENSE
Interest Expense - - $69.47M
Other Income/Expense $786.00K $834.00K $37.00K
Pretax Income $-501.09M $-5.05M $-151.12M
Income Tax $-3.34M $2.27M $154.00K
Net Income $-257.13M $-2.93M $-63.26M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-20.17 $-0.66 $-7.19
Diluted Shares 12.94M 9.98M 9.29M
EBITDA $-403.34M $4.79M $-69.99M
Depreciation & Amortization $9.56M $11.83M $11.69M
Balance Sheet
ASSETS
Cash & Equivalents $32.90M $40.92M $90.81M
Accounts Receivable $72.00K $4.45M $250.00K
Other Current Assets $13.17M $34.64M $49.17M
Current Assets $285.79M $400.41M $476.44M
PP&E (Net) $5.15M $29.32M $26.84M
Intangible Assets $0 $302.50M $396.55M
Other Noncurrent Assets $1.30M $3.72M $2.26M
Noncurrent Assets $701.59M $1.09B $1.02B
Total Assets $987.38M $1.49B $1.50B
LIABILITIES
Accounts Payable $6.92M $14.59M $17.71M
Short-term Debt $0 $39.50M $75.00M
Other Current Liabilities $3.33M $4.42M $5.59M
Current Liabilities $141.50M $338.05M $370.01M
Long-term Debt $636.74M $447.87M $422.71M
Other Noncurrent Liabilities $10.65M $9.20M $9.10M
Noncurrent Liabilities $851.20M $691.97M $674.60M
Total Liabilities $1.05B $1.08B $1.09B
EQUITY
Additional Paid-in Capital $727.64M $669.35M $654.06M
Retained Earnings $-680.33M $-423.21M $-420.28M
Accumulated OCI $-59.00K $-151.00K $-127.00K
Total Equity $-62.21M $405.44M $405.65M
Total Liabilities & Equity $987.38M $1.49B $1.50B
SUPPLEMENTAL
Total Debt $636.74M $487.37M $497.71M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $-121.95M $-21.61M $109.14M
Capital Expenditures $8.25M $13.73M $13.73M
Cash from Investing $-8.25M $3.81M $-13.73M
Cash from Financing $122.00M $-32.03M $-21.11M
Free Cash Flow $-130.20M $-35.34M $95.41M
Beginning Cash (CFS) $40.92M $90.81M $16.46M
Net Change in Cash $-8.20M $-49.83M $74.30M
Effect of FX on Cash $182.00K $-55.00K $42.00K
Calculated Ending Cash $32.90M $40.92M $90.81M
Cash per BS $32.90M $40.92M $90.81M
Cash scope difference (CFS − BS) - - -
Cash per CFS $32.90M $40.92M $90.81M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is GoHealth, Inc.'s annual revenue?

GoHealth, Inc. reported $152.79M in revenue for trailing twelve months (ending March 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is GoHealth, Inc. profitable?

No. GoHealth, Inc. reported $-289.89M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

What is GoHealth, Inc.'s debt level?

GoHealth, Inc. carries $653.13M in total debt as of trailing twelve months. Total shareholders' equity stands at $-126.70M.

Does GoHealth, Inc. generate free cash flow?

No. Free cash flow was $-107.76M for trailing twelve months. Operating cash flow was $-102.56M.